87
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis

, , , , , , , , & show all
Pages 696-703 | Received 17 Aug 2009, Accepted 08 Nov 2009, Published online: 29 Jan 2010

References

  • Queiroz-Telles F, Esterre P, Perez-Blanco M, . Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol 2009;47:3–15.
  • Badali H, Carvalho VO, Vicente V, . Cladophialophora saturnica sp. nov., a new opportunistic species of Chaetothyriales revealed using molecular data. Med Mycol 2009;47:51–62.
  • Badali H, Gueidan C, Najafzadeh MJ, . Biodiversity of the genus Cladophialophora. Stud Mycol 2008;61:175–191.
  • Badali H, Najafzadeh MJ, Van Esbroeck M, . The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species. Med Mycol 2009;29:1–10.
  • Queiroz-Telles F, McGinnis MR, Salkin I, . Subcutaneous mycoses. Infect Dis Clin North Am 2003;17:59–85.
  • Padhye AA, Ajello L. A case of chromoblastomycosis with special reference to the mycology of the isolated Exophiala jeanselmei. Mykosen 1987;30:134.
  • Piepenbring M, Ca'ceres Mendez OA, Espino Espinoza A, . Chromoblastomycosis caused by Chaetomium funicola: a case report from Western Panama. Brit J Derm 2007;157:1025–1029.
  • Crous PW, Braun U, Groenewald JZ. Mycosphaerella is polyphyletic. Stud Mycol 2007;58:1–32.
  • Campolina SS, Caligiorne RB, Rezende-Silva S, . A skin infection mimicking chromoblastomycosis by a Capnodialean fungus. Med Mycol [E-pub Ahead of print 29 july 2009. DOI 10.1080/13693780903148353] 2009;47:81–85.
  • Carrión AL. Chromoblastomycosis. Ann N Y Acad Sci 1950;50:1255–1282.
  • Ogawa MM, Alchorne MM, Barbieri A, . Lymphoscinti-graphic analysis in chromoblastomycosis. Int J Dermatol 2003;42:622–625.
  • Takase T, Baba T, Uyeno K. Chromomycosis. A case with a widespread rash, lymph node metastasis and multiple subcutaneous nodules. Mycoses 1988;31:343–352.
  • Muhammed K, Nandakumar G, Asokan KK, Vimi P. Lymphangitic chromoblastomycosis. Indian J Dermatol Venereol Leprol 2006;72:443–445.
  • Borelli D. Acrotheca aquaspersa nova sp., agente de cromomicosis. Acta Cient Venez 1972;23:193–196.
  • Arango M, Jaramillo C, Cortes A, Restrepo A. Auricular chromoblastomycosis caused by Rhinocladiella aquaspersa. Med Mycol 1998;36:43–45.
  • Marques S G, Pedrozo Silva CM, Resende MA, . Chromoblastomycosis caused by Rhinocladiella aquaspersa. Med Mycol 2004;42:261–265.
  • Sutton D A, Slifkin M, Yakulis R, Rinaldi MG. U.S. case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): criteria for identification, therapy, and review of other known dematiaceous neurotropic taxa. J Clin Microbiol 1998; 36: 708–715.
  • Campbell CL, Al-Hedaithy SS. Phaeohyphomycosis of the brain caused by Ramichloridiwn mackenziei sp. nov. in Middle Eastern countries. J Med Vet Mycol 1993;31:325–332.
  • Gams W, Verkley GJM, Crous PW. CBS Course of Mycology, 5th. Utrecht, The Netherlands: Centraalbureau voor Schimmelcultures, 2007.
  • De Hoog GS, Guarro J, Gene J, Figueras MJ. Atlas of Clinical Fungi, 2nd. Utrecht/Reus: Centraalbureau voor Schimmelcultures/Universitat Rovira i Virgili, 2000.
  • Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved Standard M38-A2; 2nd: CLSI, Wayne, PA, USA, 2008.
  • Arzanlou M, Groenewald JZ, Gams W, . Phylogenetic and morphotaxonomic revision of Ramichloridium and allied genera. Stud Mycol 2007; 58: 57–93.
  • Schell WA, McGinnis MR, Borelli D. Rhinocladiella aquaspersa a new combination for Acrotheca aquaspersa. Mycotaxon 1983;17:341–348.
  • Jae BJ, Park YJ, Kim DW, Suh SB. Chromoblastomycosis caused by Rhinocladiella aquaspersa. Kor J Med Mycol 2004;9:117–122.
  • Pires dAvila SCG, Pagliari C, Duarte MIS. The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease. Mycopathologia 2002;156:51–60.
  • Corbellini VA, Scroferneker ML, Carissimi M, Santolin LD. Delayed-type hypersensitivity response to crude and fractionated antigens from Fonsecaea pedrosoi CMMI 1 grown in different culture media. Mycopathologia 2006;162:51–55.
  • Iwatsu T, Miyaji M, Taguchi H, Okamoto S. Evaluation of skin test for chromoblastomycosis using antigens prepared from culture filtrates of Fonsecaea pedrosoi, Phialophora verrucosa, Wangiella dermatitidis and Exophiala jeanselmei. Mycopathologia 1982;77:59–64.
  • Ahrens J, Graybill JR, Abishawl A, . Experimental murine chromomycosis mimicking chronic progressive human disease. Am J Trap Med Hyg 1989;40:651–658.
  • Esterre P, Queiroz-Telles F. Managements of chromoblastomycosis: novel perspectives. Curr Opin Infect Dis 2006;19:148–152.
  • Cardona-Castro N, Agudelo-Flórez P. Development of a chronic chromoblastomycosis model in immunocompetent mice. Med Mycol 1999;37:81–83.
  • De Hoog GS, Nishikaku AS, Fernández Zeppenfeldt G, . Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species. Stud Mycol 2007;58:219–234.
  • Harutyunyan S, Muggia L Grube M. Black fungi in lichens from seasonally arid habitats. Stud Mycol 2008;61:83–90.
  • Bonifaz A, Paredes-Solís V, Saúl A. Treating chromoblastomycosis with systemic antifungals. Exp Opin Pharmacother 2004;5:247–254.
  • Bonifaz A, Saul A, Paredes-Solis V, Araiza J, Fierro-Arias L. Treatment of chromoblastomycosis with terbinafine: experience with four cases. J Dermatol Treat 2005;16:47–51.
  • Vanden Bossche H, Dromer F, Improvisi I, . Antifungal drug resistance in pathogenic fungi. Med Mycol 1998;38:119–128.
  • Gonzalez GM, Fothergill AW, Sutton DA, . In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi. Med Mycol 2005;43:281–284.
  • Cuenca-Estrella M, Gomez-Lopez A, Mellado E, . Head-to-head comparison of the activities of currently available antifungal agents against 3378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother 2006;50:917–921.
  • Odabasi Z, Paetznick VL, Rodriguez JR, . In vitro activity of anidulafungin against selected clinically important mold isolates. Anti-microb Agents Chemother 2004;48:1912–1915.
  • Badali H, De Hoog GS, Curfs-Breuker I, . In vitro activities of eight antifungal drugs against 70 clinical and environmental isolates of Alternaria species. J Antimicrob Chemother 2009; 63: 1295–1297.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.